NCT00223262View on ClinicalTrials.gov

Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Memory Impairment Due to Corticosteroid UseHypomania Due to Corticosteroid UseHippocampal Atrophy Due to Corticosteroid
Interventions
DRUG

Lamotrigine (Drug)

Trial Locations (1)

75390-8843

The UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT00223262 - Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients | Biotech Hunter | Biotech Hunter